[Sudden relief of symptoms in a patient with mesangiocapillary glomerulonephritis during treatment of hematuria with epsilon aminocaproic acid].
A case of not expected turn in the course of mesangiocapillary glomerulonephritis in a 30-year old patient is presented. The patient has been treated with EACA. It confirms possible efficiency of EACA inhibitory effect on various immunological reactions. This new, unknown property of EACA justify some new concepts in pathogenetic mechanisms of glomerulopathy.
Kuźniar
J
J
Katedry i Kliniki Nefrologii AM we Wrocławiu.
Szewczyk
Z
Z
D000328:Adult; D015119:Aminocaproic Acid / Q000627:therapeutic use*; D015432:Glomerulonephritis, Membranoproliferative / Q000150:complications*; D006417:Hematuria / Q000150:complications / Q000188:drug therapy*; D006801:Humans; D008297:Male; D016896:Treatment Outcome
D015119:Aminocaproic Acid
Nagłe ustapienie objawów choroby u chorego na mezangiokapilarne kłebkowe zapalenie nerek podczas leczenia krwiomoczu kwasem epsilon-aminokapronowym.